Skip to content
10-Q

Quarterly Report

Tobira Therapeutics, Inc.

0001564590-16-023667

← back to feed
Filed
Aug 9, 2016 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2016 · Aug 5, 2016 18.82M sh
Long Term Debt Q2 2016 · Jun 30, 2016 $12.62M
Long Term Debt Q2 2016 · Dec 31, 2015 $15.01M
Cash And Equivalents Q2 2016 · Jun 30, 2016 $40.69M
Cash And Equivalents Q2 2016 · Dec 31, 2015 $62.43M
Cash And Equivalents Q2 2016 · Jun 30, 2015 $63.39M
Cash And Equivalents Q2 2016 · Dec 31, 2014 $6.18M
Stockholders Equity Q2 2016 · Jun 30, 2016 $19.76M
Stockholders Equity Q2 2016 · Dec 31, 2015 $42.77M
Current Liabilities Q2 2016 · Jun 30, 2016 $12.1M
Current Liabilities Q2 2016 · Dec 31, 2015 $7.42M
Total Liabilities Q2 2016 · Jun 30, 2016 $24.88M
Total Liabilities Q2 2016 · Dec 31, 2015 $22.64M
Current Assets Q2 2016 · Jun 30, 2016 $42.39M
Current Assets Q2 2016 · Dec 31, 2015 $63.23M
Total Assets Q2 2016 · Jun 30, 2016 $44.64M
Total Assets Q2 2016 · Dec 31, 2015 $65.41M
Sga Expense Q2 2016 · Jun 30, 2016 $3.13M
Sga Expense Q2 2016 · Jun 30, 2016 $6.47M
Sga Expense Q2 2016 · Jun 30, 2015 $3.12M
Sga Expense Q2 2016 · Jun 30, 2015 $5.27M
Rd Expense Q2 2016 · Jun 30, 2016 $10.88M
Rd Expense Q2 2016 · Jun 30, 2016 $19.56M
Rd Expense Q2 2016 · Jun 30, 2015 $6.62M
Rd Expense Q2 2016 · Jun 30, 2015 $12.29M
Net Income Q2 2016 · Jun 30, 2016 −$13.34M
Net Income Q2 2016 · Jun 30, 2016 −$25.56M
Net Income Q2 2016 · Jun 30, 2015 −$10.99M
Net Income Q2 2016 · Jun 30, 2015 −$18.02M
Operating Income Q2 2016 · Jun 30, 2016 −$12.95M
Operating Income Q2 2016 · Jun 30, 2016 −$24.86M
Operating Income Q2 2016 · Jun 30, 2015 −$9.74M
Operating Income Q2 2016 · Jun 30, 2015 −$17.56M
Capex Q2 2016 · Jun 30, 2015 $31K